Leef Brands (LEEEF) Accounts Payables (2023 - 2026)
Leef Brands (LEEEF) reported Accounts Payables of $5.2 million for Q1 2026, up 9.26% sequentially from $4.8 million in Q4 2025.
Leef Brands (LEEEF) Accounts Payables (2023 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 4 years of Accounts Payables data on file, last reported at $5.2 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (changed N/A YoY), and the FY2025 full-year result was $4.8 million, down 27.9% from the prior year.
- Accounts Payables rose to $5.2 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $7.0 million in Q4 2023 to a low of $4.8 million in Q4 2025.
- A 4-year average of $5.9 million and a median of $5.9 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables retreated 5.32% in 2024 and declined 27.9% in 2025, its largest moves.
- Tracing LEEEF's Accounts Payables over 4 years: stood at $7.0 million in 2023, then slipped by 5.32% to $6.6 million in 2024, then decreased by 27.9% to $4.8 million in 2025, then gained by 9.26% to $5.2 million in 2026.
- Business Quant data shows LEEEF's Accounts Payables at $5.2 million in Q1 2026, $4.8 million in Q4 2025, and $6.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 6.61 Mn |
| Dec 31, 2023 | 6.99 Mn |